1-(3-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine, 97%, 100mg

2-HYDROXY-1-(MORPHOLIN-4-YL)ETHAN-1-ONE, 95.0%, 100g

Cyclotrimethylenedimethylsilane, 5g

6-(4-Chlorophenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile, 97.0%, 10g

5-Bromo-7-methyl-1-benzofuran-3-carboxylic acid, 95%, 2.5g

Ethyl 4,6-dichloro-5-nitronicotinate, 95.0%, 10g

6-Methoxyquinazolin-4-ol, 95.0%, 10g

1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide Hydrochloride [Coupling Agent for Peptides Synthesis]>98.0%(T)250g

(E)-2-(2,6-Dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenoxy)-2-methylpropanoic acid, 95.0%, 1g

Calciumgluconathydrat 2,5 g

3,4,5-Trimethoxytoluene, 95.0%, 1kg

2,3-Dihydrobenzofuran-7-ol, 95+%, 1g

4-Acetamidobenzenesulfonyl Azide>98.0%(HPLC)25g